본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019
()

Choi Hwa Young
(Department of Cancer Control and Population Health)
. Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019. JOURNAL OF GASTROENTEROLOGY. 2023-05-17; 2023; 58(7):682~692. IF 6.3 (2022)
Mutational evolution after chemotherapy-progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis
()

Cha Yongjun
(Bioinformatics Branch)
. Mutational evolution after chemotherapy-progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis. INTERNATIONAL JOURNAL OF CANCER. 2023-05-16; 2023; 153(3):571~583. IF 6.4 (2022)
External Validation of the eCura System for Undifferentiated-Type Early Gastric Cancer with Noncurative Endoscopic Resection Choi il Ju
(Cancer Epidemiology Branch)

Kim, Young Il
(Cancer Epidemiology Branch)
. External Validation of the eCura System for Undifferentiated-Type Early Gastric Cancer with Noncurative Endoscopic Resection. GUT AND LIVER. 2023-05-10; 2023; 17(4):537~546. IF 3.4 (2022)
nc886, an RNA Polymerase III-Transcribed Noncoding RNA Whose Expression Is Dynamic and Regulated by Intriguing Mechanisms Lee Yong Sun
(Department of Cancer Biomedical Science)

Lee Yeon Su
(Rare & Pediatric Cancer Branch)
. nc886, an RNA Polymerase III-Transcribed Noncoding RNA Whose Expression Is Dynamic and Regulated by Intriguing Mechanisms. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023-05-10; 2023; 24(10):8533~. IF 5.6 (2022)
The Regulatory Roles of Mitochondrial Metabolism Dynamics and Mitochondria Calcium Uniporter (MCU) in Bevacizumab Resistance of GBM Kim Sung Soo
(Department of Cancer Biomedical Science)

Kim ye jin
(NCCGCSP Research and Development Business Foundati)
. The Regulatory Roles of Mitochondrial Metabolism Dynamics and Mitochondria Calcium Uniporter (MCU) in Bevacizumab Resistance of GBM. ADVANCED THERAPEUTICS. 2023-05-05; 2023; 6(7):2300067~. IF 4.6 (2022)
Development of a Bispectral index score prediction model based on an interpretable deep learning algorithm KIM JUNE TAE
(Department of Cancer AI and Digital Health)


()
. Development of a Bispectral index score prediction model based on an interpretable deep learning algorithm. ARTIFICIAL INTELLIGENCE IN MEDICINE. 2023-05-02; 2023; 143:102569~. IF 7.5 (2022)
(grant 수정 필요)Liver Kinase B1 Mediates Its Anti-Tumor Function by Binding to the N-Terminus of Malic Enzyme 3 Rho Seung Bae
(Cancer Metastasis Branch)

Rho Seung Bae
(Cancer Metastasis Branch)
. (grant 수정 필요)Liver Kinase B1 Mediates Its Anti-Tumor Function by Binding to the N-Terminus of Malic Enzyme 3. BIOMOLECULES & THERAPEUTICS. 2023-05-01; 2023; 31(3):330~339. IF 3.7 (2022)
Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)

Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)
. Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis. OSTEOPOROSIS INTERNATIONAL. 2023-04-29; 2023; Online:Published. IF 4 (2022)
Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer LIM MYONG CHEOL
(Center for Uterine Cancer)

Kim Ji Hyun
(Department of Obstetrics and Gynecology)
. Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer. JOURNAL OF OVARIAN RESEARCH. 2023-04-29; 2023; 16(1):85~. IF 4 (2022)
Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors
()

CHOI DONG WOO
(Data Link & Operation Team)
. Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors. CANCER. 2023-04-28; 2023; :~. IF 6.2 (2022)